MRD levels during the first months of treatment indicate relapses in children with t(12;21)-positive ALL [3]

Leukemia

Volumn 14, Issue 9, 2000, Pages 1707-1708

  Fasching, K ^a   Konig, M ^a   Hettinger, K ^a   Mann, G ^a   Gadner, H ^a   Haas, O A ^a   Panzer Grumayer, E R ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; B CELL LEUKEMIA; CANCER RECURRENCE; CHILD; CHROMOSOME TRANSLOCATION 12; CHROMOSOME TRANSLOCATION 21; CONTROLLED STUDY; FOLLOW UP; GENE REARRANGEMENT; GENETIC LINKAGE; HIGH RISK POPULATION; HUMAN; INFANT; LETTER; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033832599     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401882     Document Type: Letter

References (6)

1. The role of TEL fusion genes in pediatric leukemias
2. Prognostic value of minimal residual disease in acute lymphoblastic leukemia in childhood
3. Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia
4. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets. Report of BIOMED-1 CONCERTED ACTION: Investigation of minimal residual disease in acute leukemia
5. Konzeption und Zwischenergebnis der Therapiestudie ALL-BFM 90 zur Behandlung der akuten lymphoblastischen Leukamie bei Kindern und Jugendlichen: Die Bedeutung des initialen Therapieansprechens in Blut und Knochenmark